statements or the risk
factors contained in our quarterly report on Form 10-Q for the quarter
ended June 28, 2008, whether as a result of new information, future events
or otherwise, except as may be required under the federal securities laws.
Contact:
Dana Banks
Masimo Corporation
949-297-7348
Masimo, SET, Signal Extraction Technology, Improving Outcomes and
Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and
Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Radical-7, Rad-87,
Rad-57, Rad-9, Rad-8, Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are
trademarks or registered trademarks of Masimo Corporation.
'/>"/>SOURCE Masimo Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related biology technology :1.
Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business2.
Masimo Reports Second Quarter 2007 Financial Results3.
Masimo Launches Patient SafetyNet and Showcases the Rainbow SET Upgradable Noninvasive Monitoring Platform at 2007 ASA Annual Meeting4.
Masimo to Report Third Quarter 2007 Financial Results on October 30, 20075.
Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan6.
Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology7.
Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group8.
Masimo Announces Continuous Noninvasive Total Hemoglobin9.
Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results10.
Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference11.
Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide